Skip to main content
. 2021 Jan 1;12(3):682–692. doi: 10.7150/jca.46379

Figure 6.

Figure 6

Genomic alteration and prognosis of m6A regulators in eight PCa studies (cBioportal). (A) OncoPrint of 10 m6A regulators in PCa. (B) DFS/ progression-free survival (PFS) of patients with PCa who had altered (red) and unaltered (blue) mRNA expression of the m6A regulators. (C) Genetic alteration frequencies of the 10 m6A regulators in PCa.